BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17385682)

  • 1. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients.
    Isaksson A; Berggren M; Ekeland-Sjöberg K; Samuelsson T; Ricksten A
    J Med Virol; 2007 May; 79(5):573-81. PubMed ID: 17385682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus U leader exon contains an internal ribosome entry site.
    Isaksson A; Berggren M; Ricksten A
    Oncogene; 2003 Jan; 22(4):572-81. PubMed ID: 12555070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative EBNA1 expression in organ transplant patients.
    Berggren MA; Isaksson A; Larsson U; Nilsson F; Nyström U; Ekman T; Löfvenmark J; Ricksten A
    J Med Virol; 2005 Jul; 76(3):378-85. PubMed ID: 15902706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement in oncogenesis of a single base mutation in an internal ribosome entry site of Epstein-Barr nuclear antigen 1 mRNA.
    Endo R; Kikuta H; Ebihara T; Ishiguro N; Kobayashi K
    J Med Virol; 2004 Apr; 72(4):630-4. PubMed ID: 14981766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
    Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
    Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8.
    Ba Abdullah MM; Palermo RD; Palser AL; Grayson NE; Kellam P; Correia S; Szymula A; White RE
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent gene EBNA-1 genetic diversity among transplant patients compared with patients with infectious mononucleosis.
    Sullivan K; Isabel S; Khodai-Booran N; Paton TA; Abdulnoor M; Dipchand AI; Hébert D; Ng VL; Allen UD
    Clin Transplant; 2019 Apr; 33(4):e13504. PubMed ID: 30790353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders.
    Schuster V; Ott G; Seidenspinner S; Kreth HW
    Infection; 2000; 28(3):137-42. PubMed ID: 10879636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.
    Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T
    Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene variations of Epstein-Barr virus nuclear antigen 3A in nasopharyngeal carcinomas, gastric carcinomas and healthy carriers in northern China.
    Wang X; Wu G; Wang Y; Sun Z; Luo B
    Arch Virol; 2013 Oct; 158(10):2041-8. PubMed ID: 23605669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.
    Bell MJ; Brennan R; Miles JJ; Moss DJ; Burrows JM; Burrows SR
    J Infect Dis; 2008 Jun; 197(11):1594-7. PubMed ID: 18419576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.
    Falk K; Gratama JW; Rowe M; Zou JZ; Khanim F; Young LS; Oosterveer MA; Ernberg I
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():779-90. PubMed ID: 9049323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular target genes of Epstein-Barr virus nuclear antigen 2.
    Maier S; Staffler G; Hartmann A; Höck J; Henning K; Grabusic K; Mailhammer R; Hoffmann R; Wilmanns M; Lang R; Mages J; Kempkes B
    J Virol; 2006 Oct; 80(19):9761-71. PubMed ID: 16973580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transcription by the Epstein-Barr virus nuclear antigen EBNA 2.
    Palermo RD; Webb HM; Gunnell A; West MJ
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):625-8. PubMed ID: 18631129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
    Tanaka M; Yokoyama A; Igarashi M; Matsuda G; Kato K; Kanamori M; Hirai K; Kawaguchi Y; Yamanashi Y
    J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis.
    Masuoka S; Kusunoki N; Takamatsu R; Takahashi H; Tsuchiya K; Kawai S; Nanki T
    PLoS One; 2018; 13(12):e0208957. PubMed ID: 30533036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.